Mutares AG, a German private equity investor, has sold Suir Pharma to Saneca Pharmaceuticals for an undisclosed consideration.
Suir Pharma is an independent contract manufacturing company working with many established pharmaceutical companies worldwide. Suir Pharma (formerly a Stada AG manufacturing site) is well known as a manufacturer of generic medicines with the highest quality standards. The company currently supplies various markets in Europe and has been supplying the USA since 1988.
Saneca Pharmaceuticals is a supplier to the global pharmaceutical and healthcare industry. A privately owned company, Saneca Pharmaceuticals develops and produces high quality pharmaceutical dosage forms, including solid, liquids, gels and creams. The company's entire portfolio covers a wide range of therapeutic categories, and reaction capabilities. Saneca Pharmaceuticals was established originally in 1940 and is located in Slovakia.
Oaklins' team in Ireland advised the seller in this transaction.
© Oaklins. All rights reserved. Oaklins refers to Oaklins International Inc. and/or one of its member firms, each of which is a separate legal entity. Please see www.oaklins.com/legal for further details.